Form 4: Syros Pharmaceuticals Director Timothy Tyson Acquires Shares and Options

Director Timothy Tyson acquired 4,000 shares of common stock and options to purchase 6,000 shares of Syros Pharmaceuticals on June 5, 2024.

Summary

• On June 5, 2024, Timothy Tyson, a director of Syros Pharmaceuticals, acquired 4,000 shares of common stock at $0.00 per share.
• On the same date, Tyson also acquired options to purchase 6,000 shares of common stock at an exercise price of $5.30.
• Following these transactions, Tyson directly owns 33,189 shares of common stock and options for 6,000 shares.
• The stock options vest over a one-year period, with 50% vesting after six months and the remainder vesting in equal monthly installments.

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a standard regulatory filing. The acquisition of shares and options by a director could be seen as a slightly positive signal, but it's not definitive.

Positives

• A director's acquisition of shares and options may signal confidence in the company's future prospects.

Industry Context

Form 4 filings are standard disclosures required by the SEC when insiders (officers, directors, or those holding more than 10% of a company's shares) buy or sell their company's stock. These filings are closely watched by investors for signals about management's view of the company's prospects.

Comparison to Industry Standards

• Insider transactions are common across publicly traded companies, and the reporting requirements are standardized by the SEC.
• The size and frequency of insider transactions can vary widely depending on the company's size, industry, and specific circumstances.
• Comparing Tyson's transactions to those of other directors in similar-sized biotech companies could provide additional context, but would require further research.

Stakeholder Impact

• The acquisition of shares by a director could be viewed positively by shareholders, potentially increasing confidence in the company.

Key Dates

Keywords

Syros Pharmaceuticals, Director, Insider Trading, Stock Options, Common Stock, Acquisition, Form 4, Ownership